Prof. Michael Edelstein

Associate Professor פרופ' חבר
Bar-Ilan Email
Fields of Interest

public health, epidemiology, infectious diseases, digital health, health inequities, health service delivery and evaluation, infectious Diseases

Research field
Public Health and Epidemiology

Professor Michael Edelstein is a UK-trained Public Health physician specializing in infectious disease and vaccine epidemiology. He joined the Bar-Ilan University Azrieli Faculty of Medicine, based in Safed, as associate professor, in August 2020. His major research interests focus on the equitable delivery of public health programs, harnessing digital tools (and data in particular) to improve public health, applied principally, but not exclusively, to immunization programs.

Prior to joining Bar-Ilan University, Professor Edelstein was responsible for improving vaccine coverage data and optimizing the quality and use of data to improve the national immunization program across the life-course and to reduce inequalities at PHE, England’s national public health agency. He was also a member of England’s national COVID-19 surveillance team. As an honorary associate professor of Public Health at London School of Hygiene and Tropical Medicine, his research focused on barriers and enablers to reducing health inequalities in vaccine programs. He was the president of the infectious diseases section of the European Public Health Association (EUPHA) between 2018 and 2021.

Professor Edelstein is also deputy editor of the journal Epidemiology and Infection, and a fellow of the UK Faculty of Public Health. He serves on the national immunization advisory committee to the Israeli Ministry of Health, and has served on expert groups for the World Health Organization and the European Centre for Disease Prevention and Control. He has over 65 peer-reviewed publications

He can be followed on Twitter: @epi_michael and is always interested in hearing from students with innovative research ideas!



    Implementation and evaluation of equitable public health interventions


    Selected Recent publications:


    • Michael Edelstein, Karine Wiegler Beiruti, Hila Ben-Amram, Naor Bar-Zeev, Christian Sussan, Hani Asulin, David Strauss, Younes Bathish, Salman Zarka, Kamal Abu Jabal. Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021. Clinical Infectious Diseases (accepted for publication)
    • Dror AA, Morozov N, Daoud A, Namir Y, Yakir O, Shachar Y, Lifshitz M, Segal E, Fisher L, Mizrachi M, Eisenbach N, Rayan D, Gruber M, Bashkin A, Kaykov E, Barhoum M, Edelstein M, Sela E. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS One. 2022 Feb 3;17(2):e0263069. 
    • Gorelik Y., Anis E., Edelstein M. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. Lancet Regional Health: Europe. 2022 Jn 12
    • Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S, Edelstein M. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021 Feb;26(6):2100096. doi: 10.2807/1560-7917.ES.2021.26.6.2100096.
    • Yom-Tov E, Lampos V, Inns T, Cox IJ, Edelstein M. Providing early indication of regional anomalies in COVID-19 case counts in England using search engine queries. Sci Rep. 2022 Feb 11;12(1):2373. doi: 10.1038/s41598-022-06340-2.4
    • Digital technologies in the public-health response to COVID-19.
    • Budd J, Miller BS, Manning EM, Lampos V, Zhuang M, Edelstein M, Rees G, Emery VC, Stevens MM, Keegan N, Short MJ, Pillay D, Manley E, Cox IJ, Heymann D, Johnson AM, McKendry RA. Nat Med. 2020 Aug;26(8):1183-1192. doi: 10.1038/s41591-020-1011-4. Epub 2020 Aug 7.
    • Does the use of personal electronic health records increase vaccine uptake? A systematic review.
    • Balzarini F, Frascella B, Oradini-Alacreu A, Gaetti G, Lopalco PL, Edelstein M, Azzopardi-Muscat N, Signorelli C, Odone A. Vaccine. 2020 Aug 27;38(38):5966-5978. doi: 10.1016/j.vaccine.2020.05.083. Epub 2020 Jun 30.
    • Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020.
    • McDonald HI, Tessier E, White JM, Woodruff M, Knowles C, Bates C, Parry J, Walker JL, Scott JA, Smeeth L, Yarwood J, Ramsay M, Edelstein M. Euro Surveill. 2020 May;25(19):2000848. doi: 10.2807/1560-7917.ES.2020.25.19.2000848.
    • Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.
    • Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, Bai X, Lucidarme J, Borrow R, Ramsay ME. N Engl J Med. 2020 Jan 23;382(4):309-317. doi: 10.1056/NEJMoa1901229.
    • Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland.
    • Edelstein M, White J, Bukasa A, Saliba V, Ramsay M. Bull World Health Organ. 2019 Nov 1;97(11):754-763. doi: 10.2471/BLT.18.229138. Epub 2019 Aug 23.

    Last Updated Date : 06/02/2023